Initial observations of Jinhua Qinggan Granules, a Chinese medicine, in the mitigation of hospitalization and mortality in high-risk elderly with COVID-19 infection: A retrospective study in an old age home in Hong Kong

Front Med (Lausanne). 2022 Jul 27:9:948149. doi: 10.3389/fmed.2022.948149. eCollection 2022.

Timothy P H Lin¹, Edith M C Lau¹, Kelvin H Wan¹, Linda Zhong², Enne Leung¹, Chung Nga Ko¹, Aiping Lu^{1

2}, Muhammad R Shah³, Zhaoxiang Bian^{1

2}, Dennis S C Lam^{1

2}

¹ Hong Kong Alliance of Integrated Medicine Against Covid, Hong Kong, Hong Kong SAR, China.
² School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong SAR, China.
³ Center for Bioequivalence Studies and Clinical Research (CBSCR), ICCBS, University of Karachi, Karachi, Pakistan.

No abstract available

Keywords: COVID-19; Chinese medicine; Jinhua Qinggan Granules (JHQG); Omicron; SARS-CoV-2.